company background image
FEROZ logo

Ferozsons Laboratories KASE:FEROZ Stock Report

Last Price

PK₨245.21

Market Cap

PK₨10.7b

7D

-1.4%

1Y

81.5%

Updated

21 Jun, 2024

Data

Company Financials +

Ferozsons Laboratories Limited

KASE:FEROZ Stock Report

Market Cap: PK₨10.7b

FEROZ Stock Overview

Engages in the importing, manufacturing, and sale of pharmaceutical products and medical devices in Pakistan and internationally.

FEROZ fundamental analysis
Snowflake Score
Valuation1/6
Future Growth2/6
Past Performance4/6
Financial Health4/6
Dividends0/6

Ferozsons Laboratories Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Ferozsons Laboratories
Historical stock prices
Current Share PricePK₨245.21
52 Week HighPK₨264.40
52 Week LowPK₨133.11
Beta0.70
11 Month Change1.60%
3 Month Change11.38%
1 Year Change81.48%
33 Year Change-14.41%
5 Year Change215.78%
Change since IPO11,501.20%

Recent News & Updates

Recent updates

Shareholder Returns

FEROZPK PharmaceuticalsPK Market
7D-1.4%0.4%2.5%
1Y81.5%91.3%64.4%

Return vs Industry: FEROZ underperformed the PK Pharmaceuticals industry which returned 91.3% over the past year.

Return vs Market: FEROZ exceeded the PK Market which returned 64.4% over the past year.

Price Volatility

Is FEROZ's price volatile compared to industry and market?
FEROZ volatility
FEROZ Average Weekly Movement4.6%
Pharmaceuticals Industry Average Movement5.7%
Market Average Movement5.4%
10% most volatile stocks in PK Market8.3%
10% least volatile stocks in PK Market3.1%

Stable Share Price: FEROZ has not had significant price volatility in the past 3 months.

Volatility Over Time: FEROZ's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19541,680Osman Waheedferozsons-labs.com

Ferozsons Laboratories Limited, together with its subsidiaries, engages in the importing, manufacturing, and sale of pharmaceutical products and medical devices in Pakistan and internationally. The company offers products in various therapeutic areas of anti-fungal, diabetes, anti-viral, cardiometabolic, cough, dermatology, orthopaedic, urology and nephrology, gastrointestinal and liver, antibiotics, and oncology areas. It also provides medical devices in the areas of cardiology, G.I. endoscopy, oncology, peripheral vascular disease, urology, and women's health applications.

Ferozsons Laboratories Limited Fundamentals Summary

How do Ferozsons Laboratories's earnings and revenue compare to its market cap?
FEROZ fundamental statistics
Market capPK₨10.66b
Earnings (TTM)PK₨493.87m
Revenue (TTM)PK₨15.14b

21.6x

P/E Ratio

0.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
FEROZ income statement (TTM)
RevenuePK₨15.14b
Cost of RevenuePK₨9.42b
Gross ProfitPK₨5.72b
Other ExpensesPK₨5.22b
EarningsPK₨493.87m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)11.36
Gross Margin37.77%
Net Profit Margin3.26%
Debt/Equity Ratio51.6%

How did FEROZ perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.